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Abstract. Deregulation of cell proliferation and apoptosis is
linked to malignant cell development. Leukemia is the most
frequent cancer in children, and plants are important sources
for new potential anti-cancer agents. Although anti-tumoral
effects have been shown for Pterodon pubescens extracts,
the mechanisms are still obscure. This study describes in
Pterodon pubescens a furane diterpene only reported in
Pterodon polygalaeflorus, the methyl-6·-acetoxy-7ß-
hydroxyvouacapan-17ß-oate, indicated by HRMS and 13C-
NMR analysis, and demonstrates some mechanisms of the
anti-leukemia action of its terpene subfraction SF5. SF5
induced cytotoxic and anti-proliferative effects on K562 cells.
Increased sub-G1 nuclei and Annexin V+-FITC cells confirmed
apoptosis of leukemic cells by treatment of these cells with
SF5. Down-regulation of DNMT1 gene transcription and
over-expression of Apaf-1 mRNA suggested that SF5 may be
inducing apoptosis of K562 cells by epigenetic up-regulation
of pro-apoptotic proteins involved in the mitochondrial intrinsic
pathway.
Introduction
Apoptosis appears to be an essential mechanism used by
biological organisms to maintain cell number homeostasis
but it is pivotal in the pathological process of several diseases
(1). The development of a malignant cell is linked to
deregulation of the balance between cell proliferation and
apoptosis (2). Leukemia is the most frequent malignant disease
in children. In spite of the great progress in this disease
treatment, 20-30% of the patients still die of the disease.
DNA methylation is crucial for epigenetic control of gene
transcription and the cell death by apoptosis involves complex
processes under genetic and epigenetic regulation (3). An
increased DNA methyltransferase 1 (DNMT1) expression has
been reported in a certain amount of human cancers, which
can be associated with the silencing of cell cycle inhibitors or
pro-apoptotic mediators expression (4). Apoptosis is well
characterized by features such as cell shrinking, chromatin
condensation and membrane phosphatidylserine exposure
(4,5). There are many studies suggesting that the loss of
mitochondrial transmembrane potential occurs earlier in the
commitment phase of apoptosis which results in cytochrome c
release, apoptosome assembly by interaction of cytochrome c
with the apoptotic peptidase activating factor 1 (Apaf-1) in
the cytosol, in the presence of ATP, and caspase 9 activation.
Apaf-1 is a central component of the intrinsic pathway of
apoptosis and caspase 9 activates the executioner caspase 3
and 7, responsible for degradation of many cellular substrates
(6). Since apoptosis occurs by a conserved and genetically
programmed mechanism, it has generated a hope that selective
intervention on this modulated process may influence the
course of the major degenerative diseases and cancer. Many
types of antitumor drug therapies exert their effect by activating
apoptosis (2).
Natural products are important sources of new bioactive
molecules with promising chemotherapeutic properties (7). A
number of low molecular weight compounds are currently
being investigated for their pharmacological properties in
regulating apoptosis. Pterodon pubescens Benth., Legu-
minosae, popularly known as ‘Sucupira branca’, is found
distributed throughout the central region of Brazil and is used
in folk medicine to treat rheumatic and inflammatory diseases
(8-10). Both pharmacological activities have already been
scientifically demonstrated (11-13). Phytochemical studies
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of Pterodon pubescens described linear diterpenes geranyl-
geraniol and 14, 15-epoxygeranylgeraniol in the seed oil with
topic protection against Schistossoma mansoni invasion in
mice by the latter (14). In 1970, two cyclic diterpenes with
vouacapan skeletal were described (15). Later, several new
diterpenes were described (13,16,17). Anti-inflammatory
effects have been reported for fractions derived from the
ethanolic extract of Pterodon pubescens containing the
diterpenes methyl-dihydroxy-vouacapan-oate, farnesol and
geranylgeraniol (13). Growth inhibition and apoptosis of
melanoma cells has also been demonstrated for the diterpene
methyl-dihydroxy-vouacapan-oate (17). The present study
describes important molecular mechanisms related to anti-
leukemic effects of a terpenic subfraction from Pterodon
pubescens (Pp) and reports the major components in this
mixture based on 13C-NMR and mass spectra (HRMS)
analysis.
Materials and methods
Plant material. Pterodon pubescens seeds were collected by
Luciana Pontes Coelho in Goiás, Brazil. The taxonomic
identity was confirmed by Haroldo Cavalcante de Lima, at the
Departamento de Botânica Sistemática, Jardim Botânico do
Estado do Rio de Janeiro, Brazil, where a voucher of the
collected specimen was deposited (RB 350279).
Extraction, fractioning and identification of methyl,6·-
acetoxy-7ß-hydroxyvouacapan-17ß-oate in SF5 subfraction.
The seeds were powdered and submitted to 100% ethanol
extraction (15 g/100 ml) at room temperature for 15 days. The
oil (EEPp) obtained (50% yield, w/w) after ethanol evaporation
was fractionated by liquid-liquid partition chromatography
using hexane. The EEPp was submitted to successive
extractions with hexane. After solvent evaporation, the hexanic
fraction (55% yielding) was submitted to a column chromato-
graphy (42x2.5 cm) on silica gel (Art. 7733 - Kieselgel 60,
35-70 MESH ASTM, Merck), eluted successively with
hexane, hexane/dicloromethane (1:1), hexane/ethyl acetate
(1:1), ethyl acetate, ethanol and 2% acetic acid in ethanol.
After analysis of sample gas chromatography profiles, they
were joined in eight sub-fractions. The most cytotoxic
subfraction (SF5, 32.9% yield) is a yellow, viscous and
aromatic sample, and showed the presence of a furane
diterpene, the methyl-6·-acetoxy-7ß-hydroxyvouacapan-
17ß-oate (compound 1), not described previously in this
species. Its identification was based on 13C-NMR spectra
recorded on a Bruker spectrometer (13C, 100.6 MHz), using
deuterated chloroform (CDCl3) as solvent and internal
standard (‰=0). The chemical shifts are expressed in parts
per million (ppm), reported from the central peak of deutero-
chloroform (77.16 ppm). Compound 1: ‰C 39.27 (C1), 18.28
(C2), 43.38 (C3), 33.13 (C4), 54.95 (C5), 75.54 (C6), 81.29
(C7), 42.53 (C8), 47.95 (C9), 38.71 (C10), 21.97 (C11),
150.46 (C12), 113.37 (C13), 46.37 (C14), 108.45 (C15),
141.42 (C16), 175.43 (C17), 36.18 (C18), 22.47 (C19), 15.46
(C20), 52.23 (C17-MeO). High resolution mass spectra
(HRMS) for SF5 performed on a JEOL JMS-Gcmate II,
GC/MS system spectrometer (direct probe; ionization mode;
EI+): 404.2205 (measured mass) corresponding to the
molecular formula C23H32O6 (calculated mass 404.2199),
confirmed the presence of compound 1. Mass spectral
fragmentations and 13C-NMR spectra of SF5 were compared
to those of literature.
Biological assays. The human chronic myelogenous leukemia
cell line K562 (CCL-243) was purchased from the American
Type Culture Collection (ATCC) and was cultured in supple-
mented medium. The effects of SF5 on cells were evaluated
(duplicates) by co-culture of cells with different SF5 con-
centration at 37˚C and 5% CO2. The SF5 sample was diluted
with ethanol and then with RPMI-1640 medium, supplemented
with 10% fetal bovine serum (Cultilab, Brazil), penicillin
(70 mg/l) and streptomycin (100 mg/l), until the final con-
centration of 0.01% ethanol. Control cultures received only
0.01% ethanol in supplemented medium.
MTT cytotoxicity assay. K562 cells (1x105/ml) were
cultured (triplicates) in 96 flat-bottom-wells plates (Becton
Dickinson Labware, USA), either in the absence or presence
of different SF5 concentrations in a final volume of 100 μl.
The plates were incubated for 34 h, at 37˚C, with 5% CO2.
Thereafter, cell survival was determined by the MTT assay
(18) adding 10 μl/well of a 5 mg/ml stock solution of MTT
(Sigma Chemical Co., St. Louis, MO, USA) in phosphate-
buffered saline pH 7.4 (PBS). Following incubation for 2 h,
100 μl/well of SDS 10% solution with 0.01 N HCl were added.
The extent of formazan crystal production was measured by
absorbance at 570 nm (microplate reader μQuant, Bio-Tek
Instruments, Inc.). Control cultures did not receive SF5.
Cell proliferation assay. The cells (2.5x105/ml) were cultured
in supplemented medium in 96-well flat-bottom plates
(200 μl), either in the absence or presence of different EEPp
concentrations, for 36 h, at 37˚C, in 5% CO2 (triplicates). To
assess DNA synthesis, 25 μl/well of 10 μCi/ml [3H]-methyl-
thymidine (3H-Tdr; Amersham Biosciences, Brazil) were
added at the beginning of the culture. Then, the cells were
harvested on filter paper and processed for 3H-Tdr radio-
activity determination by liquid scintillation.
Flow cytometric analysis of sub-G1 nucleus and cell shrinkage.
K562 cells (2.5x105/ml) were incubated either in the absence
or presence of 30 μg/ml of SF5 or methotrexate (MTX) for
36 h at 37˚C and 5% CO2 and processed for different analyses.
After treatment of cells with PI solution (final concentration
2 μg/ml), cell death was evaluated by high membrane
permeability to PI indicated by high fluorescence at 585 nm.
The cell shrinking was determined by analyzing cell size
with the forward-scatter (FSC) parameter of the cytometer.
Plots showing cell distribution accordingly to size (FSC) and
granularity (SSC) (not shown) were used to delimit a region
to avoid apoptotic bodies and cell debris in the analysis. To
determine the sub-G1 nuclei, cells (1x106) were centrifuged
(400 x g, 5 min), suspended in 500 μl DNA staining solution
(0.3% Triton X-100 and 50 μg/ml PI in 43 mM citrate
buffer solution pH 8.2), and maintained for 15 min at room
temperature in the dark. Later, the samples were treated with
500 μl ribonuclease A 50 μg/ml (Sigma Chemical Co.) in
43 mM citrate buffer pH 8.2 for 15 min at room temperature
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and the PI fluorescence measured. One hundred thousand
events per sample were evaluated using a FACSCalibur
cytometer (Becton Dickinson Labware). The excitation
wavelength for PI was 488 nm and the emission was detected
at 585±15 nm (19). Analysis was done with WinMdi 2.8
software.
Annexin V+-FITC flow cytometric assay. K562 cells (2.5x105/ml)
were incubated either in the absence or presence with 50 μg/ml
of SF5 or MTX for 36 h at 37˚C and 5% CO2. Phosphatidyl-
serine (PS) exposure on plasmatic membrane of apoptotic cells
was determined by Annexin-V labeling, according to the
manufacturer's instructions (Annexin V-FITC apoptosis kit,
BD Pharmingen, CA, USA). Briefly, cells (1x106) were
washed twice with cold PBS and suspended in 1 ml binding
buffer. Cells (1x105, 100 μl) were treated with Annexin V
(5 μl) and 50 μg/ml PI solution (10 μl) for 15 min at room
temperature. After addition of 400 μl of binding buffer, cells
(5x104) were acquired by Cell QuestPRO software and
analyzed using WinMdi 2.8 software. Annexin V-FITC
emission was determined by FITC fluorescence detection at
535±15 nm and PI at >670 nm by flow cytometry. Annexin V
positive cells were considered apoptotic cells. Apoptotic bodies
and cell debris were avoided as possible from analysis.
mRNA expression analysis by RT-PCR. Total RNA was
extracted from various cell samples using TRIzol reagent
according to the manufacturer's instructions (Invitrogen). The
RNA concentration was determined by optical density at
260 nm. Samples were treated with DNAse I and RNA
integrity was confirmed by agarose gel electrophoresis.
Reverse transcription reaction was performed using MMLV
reverse transcriptase (Invitrogen) with 2 μg of total RNA in a
30 μl reaction mixture containing random hexamers as
primers. The cDNA was brought into 25 μl mixture of PCR
buffer, 0.2 mM of each dNTP, 1.5 mM MgCl2, 3.2 μg of each
primer, and 2.0 units of Taq DNA polymerase platinum
(Invitrogen). The primers, annealing temperature of each
primer and cycles used were: ß-actin forward primer: 5'-TCC
TGTGGCATCCACGAAACT-3', reverse primer: 5'-GAA
GCATTTGCGGTGGACGAT-3' (59˚C, 30 cycles, 314 pb);
Apaf-1 reverse primer: 5'-TTGCTGCCCTTCTCCATGAT-3',
reverse primer: 5'-TCCCAACTGAAACCCAATGC-3'
(55˚C, 30 cycles, 334 pb); DNMT1 reverse primer: 5'-GAT
TTGTCCTTGGAGAACGG-3', reverse primer: TTGGG
TGTTGGTTCTTTGGTT-3' (57˚C, 30 cycles, 499 pb). All
genes examined were normalized to a housekeeping gene
encoding ß-actin. PCR was performed in a Perkin Elmer
GeneAmp PCR system 9600. Each PCR cycle consisted of
denaturation at 94˚C for 30 sec, annealing at specific annealing
temperature for 30 sec, and extension at 72˚C for 1 min.
Under the conditions used, the cDNAs were exponentially
amplified, and thus a semiquantitative estimation of the
products was allowed by 2% agarose gel electrophoresis.
Band intensities were quantified by using Lab Image software
(Germany).
Statistical analysis. Significant differences between pairs of
groups were accessed using Student's t-test, with a significance
level set at p<0.05.
Results
13C-NMR and HRMS analysis. The major components of
SF5, listed in Table I, were determined with basis on spectral
fragmentation analysis and its comparison to data described
in literature (13,14,16,20). The presence of compound 1, the
methyl-6·-acetoxy-7ß-hydroxyvouacapan-17ß-oate (C23H32O6)
was confirmed in SF5 by 13C-NMR analysis comparing to
data from Pterodon polygalaeflorus (16). This compound is
described here for the first time in Pterodon pubescens. Its
chemical structure is shown in Fig. 1.
SF5 effects on cell proliferation and cytotoxicity. SF5 inhibited
the incorporation of DNA synthesis in all tested concentrations
(Fig. 2A). The inhibition index (p<0.0001) ranged from 40.3 to
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Table I. Main peaks and respective fragment ions observed in the GC-MS analysis (chemical ionization/NH3) of SF5.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Rt (min) m/z Compound Ref.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
4.74 238 (M+18) Epoxyfarnesol isomer (13)
8.08 272 (M-18)a Geranylgeraniol derivative (14)
13.50 342 (M); 343 (M+1); 360 (M+18) 7ß-acetoxy vouacapan derivative (16)
14.23 404 (M); 405 (M+1); 422 (M+18) Methyl 6·-acetoxy 7ß-hydroxyvouacapan 17ß-oate (20)
14.60 464 (M+18)b 6·, 7ß-diacetoxy vouacapan 14ß-oate (16)
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
The results are expressed in retention time (Rt min) and m/z. aMolecular ion (M=290 m/z) not observed. bMolecular ion (M=446 m/z) not
observed.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Figure 1. Chemical structure of the methyl-6·-acetoxy-7ß-hydroxyvouacapan-
17ß-oate (compound 1).
74.2% when cells were treated with 10 and 40 μg/ml of SF5,
respectively. SF5 cytotoxicity to leukemic cells was con-
centration dependent (Fig. 2B). Cell viability was significantly
reduced to 70, 44 and 26%, when treated with SF5 at 30, 50
and 70 μg/ml, respectively.
SF5 effects on leukemic cell death. Treatment of K562 cells for
36 h with 30 μg/ml SF5 increased from 3.9% (control culture)
to 29.5% (treated cells) the percentage of cells with high PI
fluorescence (Fig. 3A, right marker), meaning high membrane
permeability to PI and cell commitment to death. The analysis
of cell size histograms shows that SF5 at 30 μg/ml increased
the number of cells with reduced size (shrunken), a morpho-
logic feature of cell apoptosis, compared to the control culture
(Fig. 3B). The relative number of shrinking cells (apoptotic)
after treatment with SF5 increased from 6.9% (control) to
26.7. Methotrexate, a positive drug control, showed lower
effects than SF5.
SF5 effects on the leukemia cell apoptosis. To confirm the
apoptotic status, the percentage of nuclei with sub-G1 DNA
content was determined by flow cytometry after treatment
with SF5 (30 μg/ml) for 36 h. SF5 increased from 3.8%
(untreated cells, Fig. 4A) to 16.3% (Fig. 4B) the number of
cells with sub-G1 DNA content. Methotrexate (30 μg/ml)
induced effect similar to SF5 (18.9%, Fig. 4C). Results from
three independent experiments (Fig. 4D) showed increased
number (by 14- or 9-fold) of sub-G1 nucleus following
treatment with SF5 or MTX, respectively. Induction of
apoptosis by SF5 treatment was also confirmed by PS exposure
on the outer side of plasma membrane of K562 cell, determined
by Annexin V labeling. Cells treated with SF5 (50 μg/ml)
for 36 h showed considerable increase in Annexin V-positive
cells (Fig. 5B), compared to untreated ones (Fig. 5A). The
number of Annexin V-positive cells after treatment with MTX
was lower than that of SF5. Results from three experiments
confirm the K562 cell apoptosis by treatment with SF5
(Fig. 5D).
SF5 effects on Apaf-1 and DNMT1 gene expression by RT-
PCR. In order to approach some molecular mechanisms
involved in this process cells were incubated in the absence or
presence of SF5 50 μg/ml for different times and then the
total mRNA was isolated for RT-PCR analysis of regulatory
molecules. Apaf-1 is a protein involved in the mitochondrial
pathway of apoptosis activation (intrinsic pathway) and its
promoter gene is regulated by methylation. DNA methyl-
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Figure 2. Effect of hexanic subfraction SF5 on K562 cell proliferation. (A)
DNA synthesis; (B) mitochondrial reduction activity. Cells were treated
either in the absence (control) or presence of different SF5 concentrations
for 36 h. Cell proliferation was determined by 3H-Tdr incorporation into
DNA. Cell survival was determined by the MTT assay. Results represent the
mean ± SD of three and two independent experiments, respectively, in
triplicate. **p<0.01, ***p<0.001, and ****p<0.0001 related to control by
Student's t-test.
Figure 3. Effects of SF5 hexanic subfraction on K562 cell size and membrane
permeability by flow cytometry. (A) PI fluorescence histograms; (B) Cell
size histograms. Cells (2.5x105/ml) were cultured in the absence (control) or
presence of 30 μg/ml SF5 or methotrexate (MTX) for 36 h and processed as
described in Materials and methods. Representative results from three
independent experiments.
transferases (DNMTs) hypermethylate the DNA resulting in
silencing of gene expression. Treatment with SF5 for 12, 24
and 36 h caused a progressive increase of Apaf-1 and decrease
of DNMT1 mRNA level, as can be observed by agarose gel
electrophoresis and densitometric analysis using the ß-actin
as the housekeeping gene (Fig. 6).
Discussion
Chemotherapeutic drugs induce apoptosis of tumor cells
through different mechanisms, in which signaling events play
an important role depending upon the cell type and stimulus
(2), but there are few studies on natural compounds. As SF5
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Figure 4. K562 cells apoptosis by flow cytometric analysis of sub-G1 nucleus of K562 cells treated with SF5 hexanic subfraction. Histograms of DNA
content: (A) Control, (B) SF5, and (C) MTX treated cells; (D) relative number of sub-G1 nuclei fraction (mean ± SD of three independent experiments). Cells
(2.5x105/ml) were cultured in the absence (control) or presence of 30 μg/ml SF5 or methotrexate (MTX) for 36 h and processed as described in Materials and
methods. *p<0.05 and related to control by Student's t-test.
Figure 5. K562 cells apoptosis by flow cytometric analysis of phosphatidylserine exposure on cell membrane by Annexin V-FITC labeling, after treatment
with SF5 hexanic subfraction. Histograms of Annexin V-FITC labeled cells: (A) Control, (B) SF5, and (C) MTX treated cells; (D) relative number of
Annexin V-FITC positive cells (mean ± SD from three independent experiments). Cells (2.5x105/ml) were cultured in the absence (control) or presence of
50 μg/ml SF5 or methotrexate (MTX) for 36 h and processed as described in Materials and methods. *p<0.05 and **p<0.01 related to control by Student's t-test.
inhibited leukemic cell proliferation (Fig. 2A), and this effect
is frequently associated to apoptosis induction (21), the SF5
effects on apoptosis of K562 cells were also studied.
Apoptosis is an active process of cell death detected by
different methods (6) based on specific characteristics as cell
shrinking, chromatin condensation, fragmentation of the cell
nuclei (sub-G1 nuclei), membrane blebbing and PS exposure
on the surface of cells (5,22).
Mitochondrial membrane depolarization is an early
apoptotic event, preceding PS exposure, caspase activation
and DNA condensation (23). Then, the SF5 toxic effect on
leukemic cells was evaluated (Fig. 2B) by mitochondrial
reduction activity (MTT assay). This reaction depends on
intact mitochondrial function and cell viability since mito-
chondrial MTT reduction by mitochondrial dehydrogenases
depends on reduced coenzymes supplied by viable cell
metabolism (18). The SF5 toxicity on leukemic cells was
concentration-dependent and seemed to progress into
apoptosis. Induction of K562 apoptosis by SF5 is demon-
straded by cell shrinking, increased sub-G1 nucleus and PS
exposure in the outer membrane leaflet. The translocation of
PS, which possesses a high affinity for Annexin V, is a key
signal for phagocyte recognition (24).
The apoptosis process involves several molecules with
up- and down-regulatory properties. Stimulation of pro-
apoptotic molecules or inhibition of anti-apoptotic factors is
dependent of cell type and the form of insult (6). There are
two distinct pathways for caspase activation: 1) death receptors
such as Fas can trigger caspase 8, which in turn, activates
caspase 3; 2) mitochondria can release apoptogenic factors
like cytochrome c and Apaf-1, leading to inner mitochondrial
membrane depolarization and activation of caspase 9, which
also activates caspase 3 (25). Although the activation of the
endonuclease does not require gene transcription or protein
synthesis (26), de novo synthesis or activation of many other
proteins including proteinases appears to be required to
complete apoptosis (27). Apaf-1 expression is important for
tumor suppression because it plays a central role in DNA
damage-induced apoptosis (28). The Apaf-1 gene is inactivated
in tumor progression and in the chemoresistance of some
malignancies (29). SF5 clearly induced up-regulation of the
Apaf-1 mRNA transcription in K562 cells (Fig. 6A and B).
This pro-apoptotic molecule interacts with cytochrome c and
ATP, integrating the apoptosome and converting pro-caspases
to active caspases. Since Apaf-1 is a central component of
the intrinsic pathway of apoptosis, this result suggests that
SF5 is imputing K562 cells into apoptosis through the mito-
chondrial intrinsic pathway. This finding corroborates other
reports showing anti-leukemic effect of agents by inducing
apoptosis via the mitochondrial pathway (30).
SF5 reduced the DNMT1 mRNA expression (Fig. 6A
and C), a mammalian maintenance DNA methyltransferase.
Structural features of the Apaf-1 promoter suggest that
methylation of the CpG islands serves as the major mechanism
of transcriptional regulation of Apaf-1 (3). The reduced
expression of DNMT1 in K562 cells by SF5 treatment may
be associated with hypomethylation of Apaf-1 promoter gene
resulting in its overexpression and apoptosis of leukemic
cells. Deregulation of Apaf-1 and DNMT1 gene transcription
may be contributing to the anti-tumoral effect of SF5.
This study reports for the first time the furane diterpene
methyl-6·-acetoxy-7ß-hydroxyvouacapan-17ß-oate (Fig. 1
and Table I) in Pterodon pubescens, previously described for
Pterodon polygalaeflorus. Phytochemical studies of SF5 also
indicated the presence of linear diterpenes (geranylgeraniol
and farnesol derivatives), and the furane diterpenes 7ß-acetoxy-
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Figure 6. RT-PCR analysis of the DNMT1 and Apaf-1 mRNA expression in K562 cells treated with SF5 hexanic subfraction. (A) Agarose gel
electrophoresis. Semi-quantitative analysis of: (B) Apaf-1 and (C) DNMT1 mRNAs. ß-actin mRNA was used as loading control. Cells (2.5x105/ml) were
cultured in the absence (control) or presence of SF5 (50 μg/ml). Representative results from four independent experiments.
vouacapan, 6·-7ß-diacetoxyvouacapan-17ß-oate and methyl-
6·-acetoxy-7ß-hydroxyvouacapan-17ß-oate (Table I). These
compounds were previously reported for Pterodon pubescens
(14,16, 31). Both linear or cyclic diterpenes may be involved
in the apoptotic effect of SF5 on leukemic cells since similar
vouacapan diterpenes have induced cytotoxicity and apoptosis
of melanoma cells and prostate cancer cell, respectively
(17,31), and apoptosis of leukemia U937 cells has been
reported to geranylgeraniol (32).
In conclusion, this study provides important insights into
molecular mechanisms of in vitro anti-leukemia effects of a
terpenic fraction from Pterodon pubescens. The DNMT1 gene
down-regulation and the overexpression of Apaf-1 mRNA,
induced by SF5, suggest that it may induce apoptosis of
leukemic cells by epigenetic regulation of pro-apoptotic
proteins involved in the mitochondrial intrinsic pathway. A
further challenge will be the evaluation of in vivo antitumor
potency to confirm the potential chemotherapeutic action of
SF5.
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